drugset / Trial / NCT02954484

Outcomes Of Perioperative Pregabalin On Total Knee Arthroplasty

NCT02954484

Phase 3 Completed 116 enrolled National University Hospital, Singapore
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to provide high quality evidence from a double-blinded, randomized controlled trial on the efficacy of perioperative pregabalin in reducing morphine requirements, improving pain scores and reducing chronic neuropathic pain when compared with placebo for primary total knee arthroplasty. It hence aims to improve on choice of analgesia adjuncts for total knee arthroplasty.

Timeline

Start
2015-04
Primary completion
2017-05
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pregabalin Small molecule 75 mg Oral
Comparator Acetaminophen Small molecule 1 g Oral
Comparator Etoricoxib Small molecule 120 mg Oral
Comparator Morphine Other / unclassified Intravenous
Comparator Ropivacaine Other / unclassified 0.5 %
Comparator Ropivacaine Other / unclassified 30 ml

Indications